Written by the Nuvirox Research Team
Key points
- Natrol's core product is time-release (bilayer) melatonin, sold at 1, 3, 5, and 10 mg — a fast-dissolving outer layer for sleep onset, plus a controlled-release inner layer meant to reduce wake-ups.
- The time-release concept has genuine science behind it in the prescription-grade prolonged-release melatonin studied in Europe, but Natrol's over-the-counter version hasn't been tested head-to-head against that specific formulation in published trials.
- Vitamin B6, included in most Natrol tablets, is marketed as supporting melatonin conversion, but there's no solid human trial showing it meaningfully boosts melatonin's sleep effect at the doses used.
Short answer: the time-release concept is scientifically reasonable, but Natrol's specific product hasn't been directly tested in the published trials — those exist for a related, prescription-only prolonged-release formulation. Natrol sells melatonin in a two-layer tablet: an outer layer that dissolves fast to help you fall asleep, and an inner layer designed to release melatonin more slowly through the night to "minimize wake-ups." That's a sound idea grounded in real chronobiology — but it's worth being precise about which studies actually back it, because Natrol's over-the-counter bilayer tablet is not the same product as the prescription prolonged-release melatonin used in the clinical trials people often cite.
What's the difference between "time-release" and "prolonged-release" melatonin?
The prolonged-release melatonin with the strongest published trial evidence is a specific 2 mg formulation, studied extensively in adults 55 and older with primary insomnia and licensed by regulators in Europe for that indication (Wade AG, Ford I, Crawford G, et al. Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial. BMC Med. 2010;8:51. doi:10.1186/1741-7015-8-51.). In a 6-month randomized, placebo-controlled trial of 791 adults, it showed sustained improvements in sleep quality and morning alertness scores over placebo, with no rebound insomnia on discontinuation (Lemoine P, Nir T, Laudon M, Zisapel N. Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 and older and has no withdrawal effects. J Sleep Res. 2007;16(4):372-380.). Natrol's tablets use a similar bilayer-release engineering concept and are sold in similar dose ranges (1–10 mg), but they are a distinct over-the-counter product that hasn't been the subject of its own published randomized trial that we could verify. The mechanism logic transfers reasonably well; the specific product-level evidence doesn't automatically.
Does the age cutoff in the research matter?
It might. The strongest prolonged-release melatonin trials specifically enrolled adults 55 and older, a group in whom natural melatonin production has typically declined with age — meaning supplementation is closer to replacing a genuine deficit rather than pushing levels above what a younger body already makes. If you're in your 20s or 30s with a healthy circadian rhythm, the relative benefit of a controlled-release tablet designed for reducing middle-of-the-night wake-ups is less established, since the research population and your own physiology may not match.
What about the added vitamin B6?
Vitamin B6 (pyridoxine) is a cofactor in several neurotransmitter and hormone synthesis pathways, and it's biologically plausible that adequate B6 supports the body's own melatonin and serotonin production. But that's a different claim from "adding B6 to a melatonin tablet measurably improves sleep outcomes," which is a much harder thing to demonstrate and isn't something we could verify in a dedicated human trial. Most people aren't B6 deficient to begin with, which limits how much room there is for a supplemented dose to help.
What time-release melatonin won't fix
A controlled-release tablet won't do much for insomnia driven by pain, anxiety, sleep apnea, or an irregular schedule — those need to be addressed at the source. It also won't help if your problem is falling asleep on time in the first place rather than staying asleep; for pure sleep-onset difficulty, a fast-dissolving (non-time-release) dose taken earlier in the evening is usually the more logical choice, since time-release formulations are specifically engineered to spread the dose out rather than front-load it.
Study snapshot: Prolonged-release melatonin, 6-month RCT
| Design | Randomized, double-blind, placebo-controlled |
| N | 791 adults, ages 18–80 (efficacy analysis in 55+ subgroup) |
| Duration | 3 weeks double-blind, then up to 6 months |
| Finding | Sustained sleep-quality and morning-alertness gains vs. placebo, no withdrawal rebound |
How to actually judge a melatonin dose for your situation
A useful way to sort through the 1, 3, 5, and 10 mg options Natrol sells is to separate the question by goal rather than by "strength." If your goal is shifting sleep timing (jet lag, an early flight, a shifted work schedule), lower doses (0.5–3 mg) taken at a precisely timed point relative to your target schedule tend to be favored in circadian research, because the goal is a timing signal, not sedation. If your goal is reducing middle-of-the-night wake-ups as you age and your own melatonin production has genuinely declined, the higher end of the range and a controlled-release format is more aligned with the population the core prolonged-release trials studied. Buying the highest available dose "to be safe" isn't well supported by the dose-response data in either case.
It's also worth comparing time-release melatonin against simpler alternatives before assuming the engineering matters for you specifically. If your main issue is a delayed body clock rather than fragmented sleep, a night-owl chronotype pattern responds better to light-timing strategies than to a controlled-release formulation, since the underlying problem is a shifted internal clock, not insufficient overnight melatonin availability.
Frequently asked questions
Should I take Natrol's 10 mg or the 3 mg version?
Start lower. As with most melatonin products, there isn't strong evidence that 10 mg outperforms 3–5 mg for sleep quality, and higher doses raise the odds of next-day grogginess without a clearly proportional benefit.
Is time-release melatonin better than regular melatonin for jet lag?
Not really — for circadian retiming (jet lag, shift work), a fast-acting, lower dose taken at the right time relative to your target schedule tends to matter more than sustained release, since the goal is a timing signal, not an overnight sedative effect.
Does Natrol's melatonin build tolerance with nightly use?
Melatonin isn't considered habit-forming or associated with classic tolerance/withdrawal the way sedative-hypnotics are, based on the existing trial data, including the 6-month trial above showing no rebound insomnia after stopping.
From Nuvirox
Why we formulated Sleep+ Restore
We built Sleep+ Restore around ingredients with genuine (if mixed-strength) human evidence behind them. Each serving delivers 10 mg of melatonin alongside a 905 mg blend built around L-tryptophan, L-theanine, chamomile, passionflower, ashwagandha, GABA, 5-HTP, and St. John's Wort — ingredients studied (with varying strength of evidence) for their roles in relaxation and sleep onset, not stacked as filler.
It comes with a 60-day money-back guarantee — long enough to actually evaluate it the way the research says you should.
Learn more about Sleep+ Restore →The bottom line
Natrol's time-release engineering is a reasonable idea borrowed from real prolonged-release melatonin research, but the specific over-the-counter product hasn't been independently trial-tested the way the prescription-grade version has. It's a low-risk option worth trying, especially if you're over 55 and wake frequently — just don't assume the vitamin B6 addition or the higher-dose tablets are doing more than the core melatonin dose itself.
References
- Wade AG, Ford I, Crawford G, et al. Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial. BMC Med. 2010;8:51. doi:10.1186/1741-7015-8-51.
- Lemoine P, Nir T, Laudon M, Zisapel N. Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 and older and has no withdrawal effects. J Sleep Res. 2007;16(4):372-380.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not a substitute for professional medical advice.